Cholelithiasis News and Research

RSS
Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

Study sheds light on the complex relationship between serum lipids, lipid-modifying targets, and cholelithiasis

Study sheds light on the complex relationship between serum lipids, lipid-modifying targets, and cholelithiasis

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

How does the gut microbiome affect muscle strength?

How does the gut microbiome affect muscle strength?

Metabolomic study of genetic regulation of biochemical individuality

Metabolomic study of genetic regulation of biochemical individuality

Scientific review highlights the impact of coffee on digestive organs

Scientific review highlights the impact of coffee on digestive organs

Gallstones, statins increase risk of acute pancreatitis, shows study

Gallstones, statins increase risk of acute pancreatitis, shows study

FDA approves Novo Nordisk’s weight loss injection, Saxenda

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Researchers recommend laparoscopic surgical removal of gallbladder for pediatric patients

Researchers recommend laparoscopic surgical removal of gallbladder for pediatric patients

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.